Beta Drugs Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Mar-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|
| 182 | 204 | 87 | 94 | 126 | 137 | |
| 5 | 6 | 2 | 3 | 2 | 2 | |
| 158 | 177 | 79 | 85 | 105 | 113 | |
| 88 | 105 | 33 | 37 | 50 | 62 | |
| −2 | −5 | 4 | −0.69 | 4 | −1 | |
| 18 | 19 | 17 | 19 | 20 | 20 | |
| 5 | 7 | 4 | 4 | 3 | 2 | |
| — | — | 4 | 5 | 4 | 5 | |
| 42 | 44 | 17 | 22 | 23 | 26 | |
| 29 | 39 | 19 | 21 | 29 | 32 | |
| 29 | 39 | 15 | 16 | 25 | 27 | |
| 24 | 32 | 10 | 12 | 22 | 26 | |
| 6 | 8 | 2 | 3 | 6 | 6 | |
| 18 | 24 | 9 | 9 | 16 | 19 | |
| Financial ratios | ||||||
| 16.12% | 19.17% | 22.10% | 21.89% | 23.06% | 23.30% | |
| 9.88% | 11.75% | 9.76% | 9.63% | 13.13% | 14.02% | |
| 17.81 | 47.38 | 8.40 | 8.93 | 14.78 | 16.59 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.